Clinical Trials in Baltimore

Showing 23361-23380 of 23,476 trials

Independent Studies of Dextromethorphan and of Donepezil Hydrochloride for Rett Syndrome

NCT00069550

Rett syndrome (RTT) is a disorder in which the nervous system does not develop properly. RTT generally affects girls, but there are some boys who have been diagnosed with RTT. Symptoms of RTT include small brain size, poor language skills, repetitive hand movements, and seizures. This study will evaluate the effectiveness of two drugs in treating the symptoms of RTT.

Rett Syndrome

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)90 participantsStarted Sep 2004

Baltimore, Maryland, United States

UNKNOWNPhase 3< 1 mile

Vaccine Therapy for Patients With Stage IV Melanoma

NCT00052156

This is a Phase III study in patients with melanoma that has spread to the lymph nodes and/or a distant organ, and who have had all of their cancer surgically removed. The purpose of this study is to evaluate the ability of the CancerVax™ vaccine to prevent or slow the recurrence of melanoma.

Malignant Melanoma

CancerVax Corporation670 participants

Tucson, Arizona, United States • Little Rock, Arkansas, United States • Little Rock, Arkansas, United States +74 more locations

Independent Studies of Dextromethorphan and of Donepezil Hydrochloride for Rett Syndrome

Vaccine Therapy for Patients With Stage IV Melanoma

Find Trials by Condition in Baltimore

Lidorestat (IDD 676) for the Treatment of Diabetic Neuropathy

A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal Cancer

Laser-Assisted Versus Conventional Intracytoplasmic Sperm Injection

A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS

African-American Heart Failure Trial

The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)

Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients

Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Noninvasive Prenatal Diagnosis: Using Fetal Cells From Maternal Blood

A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.

Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer

Phase III Multicenter, Open-Label, Randomized Trial of Induction Versus Induction Plus Maintenance Foscarnet ( Foscavir ) Therapy for Gastrointestinal CMV Disease

12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy.

Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System

Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV Drugs

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection

Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer

A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-Angioplasty Blood Vessel Re-Closure (Restenosis) in Stented Vessels.